ORAI1 and hepatocellular carcinoma: Consistent with the expectation, the study from Yang et al. showed that compared to control cells, the levels of cytosolic Ca2+ mediated by HBX in ORAI1-E106A (dominant-negative ORAI1 mutant)-expressing hepatoma cells were inhibited [11].